Co-Diagnostics, Inc. Common Stock (CODX) is a publicly traded Healthcare sector company. As of May 21, 2026, CODX trades at $2.47 with a market cap of $4.94M and a P/E ratio of -0.06. CODX moved +21.32% today. Year to date, CODX is -58.36%; over the trailing twelve months it is -71.03%. Its 52-week range spans $1.26 to $46.50. Rallies surfaces CODX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CoMira Finalizes Lease for Manufacturing Plant in Saudi Arabia’s Sudair City: On May 11, 2026 CoMira finalized a long-term lease for a manufacturing plant in Saudi Arabia’s Sudair Industrial City, marking its first Middle East facility. The site will support the company’s diagnostic assay production capacity and regional distribution expansion.
| Metric | Value |
|---|---|
| Price | $2.47 |
| Market Cap | $4.94M |
| P/E Ratio | -0.06 |
| EPS | $-39.08 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.50 |
| 52-Week Low | $1.26 |
| Volume | 52.32K |
| Avg Volume | 0 |
| Revenue (TTM) | $718.17K |
| Net Income | $-48.50M |
| Gross Margin | 45.06% |
CODX analyst coverage data. Average price target: $0.00.